Drugs / Gliadel Wafer
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00984438 | Jun 2009 → Jun 2010 | glioblastoma | University of Cincinnati | Withdrawn | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT00548938 | Oct 2007 → Oct 2009 | glioblastoma | Methodist Healthcare - Memphis | Terminated | No outcome recorded |
| Phase 2 | NCT00283543 | Sep 2002 → Apr 2008 | malignant glioma | Kentuckiana Cancer Institute | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gliadel Wafer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00283543 ↗ |
| Known as | BCNU Wafer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00984438 ↗ |
| Route | Other | “Implanted at surgery” NCT00548938 ↗ |